Serum Fas levels during first week of sepsis are associated with severity and mortality
INTRODUCTION: The aim of our study was to explore whether there is an association of serum sFas (cell death apoptosis receptor) concentrations during the first week of sepsis with sepsis severity and sepsis mortality.
METHODS: In this observational study, septic patients were recruited. Serum sFas concentrations were determined on days 1, 4, and 8 of sepsis diagnosis. Thirty-day mortality was the outcome variable.
RESULTS: Surviving patients (n = 181) compared to non-survivors (n = 101) presented lower serum sFas levels on day 1 (p < 0.001), day 4 (p < 0.001) and day 8 (p < 0.001), and lower SOFA on day 1 (p < 0.001), day 4 (p < 0.001) and day 8 (p < 0.001). Logistic regression analyses showed associations between 30-day mortality and serum sFas levels controlling for SOFA on day 1 (OR = 1.005; 95% CI = 1.003-1.007; p < 0.001), day 4 (OR = 1.044; 95% CI = 1.029-1.060; p < 0.001) and day 8 (OR = 1.012; 95% CI = 1.002-1.022; p = 0.02).
CONCLUSIONS: The association of serum sFas concentrations during the first week of sepsis with sepsis severity and sepsis mortality were our new findings.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Expert review of molecular diagnostics - 23(2023), 2 vom: 13. Feb., Seite 181-185 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lorente, Leonardo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Apoptosis |
|---|
| Anmerkungen: |
Date Completed 09.03.2023 Date Revised 27.03.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/14737159.2023.2179876 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM352893370 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM352893370 | ||
| 003 | DE-627 | ||
| 005 | 20231226054748.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14737159.2023.2179876 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1176.xml |
| 035 | |a (DE-627)NLM352893370 | ||
| 035 | |a (NLM)36779960 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lorente, Leonardo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Serum Fas levels during first week of sepsis are associated with severity and mortality |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.03.2023 | ||
| 500 | |a Date Revised 27.03.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a INTRODUCTION: The aim of our study was to explore whether there is an association of serum sFas (cell death apoptosis receptor) concentrations during the first week of sepsis with sepsis severity and sepsis mortality | ||
| 520 | |a METHODS: In this observational study, septic patients were recruited. Serum sFas concentrations were determined on days 1, 4, and 8 of sepsis diagnosis. Thirty-day mortality was the outcome variable | ||
| 520 | |a RESULTS: Surviving patients (n = 181) compared to non-survivors (n = 101) presented lower serum sFas levels on day 1 (p < 0.001), day 4 (p < 0.001) and day 8 (p < 0.001), and lower SOFA on day 1 (p < 0.001), day 4 (p < 0.001) and day 8 (p < 0.001). Logistic regression analyses showed associations between 30-day mortality and serum sFas levels controlling for SOFA on day 1 (OR = 1.005; 95% CI = 1.003-1.007; p < 0.001), day 4 (OR = 1.044; 95% CI = 1.029-1.060; p < 0.001) and day 8 (OR = 1.012; 95% CI = 1.002-1.022; p = 0.02) | ||
| 520 | |a CONCLUSIONS: The association of serum sFas concentrations during the first week of sepsis with sepsis severity and sepsis mortality were our new findings | ||
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Apoptosis | |
| 650 | 4 | |a mortality | |
| 650 | 4 | |a outcome | |
| 650 | 4 | |a sFas | |
| 650 | 4 | |a sepsis | |
| 650 | 7 | |a FAS protein, human |2 NLM | |
| 650 | 7 | |a fas Receptor |2 NLM | |
| 700 | 1 | |a Martín, María M |e verfasserin |4 aut | |
| 700 | 1 | |a Ortiz-López, Raquel |e verfasserin |4 aut | |
| 700 | 1 | |a González-Rivero, Agustín F |e verfasserin |4 aut | |
| 700 | 1 | |a González-Mesa, Adriana |e verfasserin |4 aut | |
| 700 | 1 | |a Villacampa-Jiménez, Jacobo J |e verfasserin |4 aut | |
| 700 | 1 | |a Jiménez, Alejandro |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez-Cejas, Antonia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert review of molecular diagnostics |d 2001 |g 23(2023), 2 vom: 13. Feb., Seite 181-185 |w (DE-627)NLM117852775 |x 1744-8352 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g number:2 |g day:13 |g month:02 |g pages:181-185 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14737159.2023.2179876 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2023 |e 2 |b 13 |c 02 |h 181-185 | ||